Laurus Labs Limited (LAURUSLABS.NS)
INR 571.5
(0.8%)
INR 571.5
(0.8%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.96 Billion | 9.93 Billion | 9.11 Billion | 7.33 Billion | 3.47 Billion | 2.97 Billion |
| Net Income | 1.6 Billion | 11.08 Billion | 10.83 Billion | 13.01 Billion | 2.93 Billion | 1.19 Billion |
| Depreciation & Amortization | 3.84 Billion | 3.24 Billion | 2.51 Billion | 2.05 Billion | 1.87 Billion | 1.64 Billion |
| Deferred income taxes | - | -2.72 Billion | -1.73 Billion | -2.38 Billion | -207.82 Million | -215.37 Million |
| Stock-based compensation | 109.2 Million | 74.8 Million | 66.4 Million | 28.9 Million | 36.7 Million | 24.2 Million |
| Change in working capital | -290.2 Million | -3.15 Billion | -3.41 Billion | -5.94 Billion | -1.99 Billion | -520.37 Million |
| Other non-cash items | 6.52 Billion | 1.4 Billion | 844.7 Million | 565.9 Million | 834.11 Million | 848.73 Million |
| Investing Cash Flow | -8.28 Billion | -9.96 Billion | -9.14 Billion | -9.4 Billion | -2.21 Billion | -2.52 Billion |
| Investments in PPE | -6.78 Billion | -9.9 Billion | -8.76 Billion | -6.88 Billion | -2.22 Billion | -2.54 Billion |
| Acquisitions | -693 Million | -223 Million | -276 Million | -2.58 Billion | 1.57 Million | 5.03 Million |
| Investment purchases | -804.2 Million | -223 Million | -393.4 Million | -1.6 Million | -660 Thousand | -40 Thousand |
| Sales/Maturities of investments | - | 91.7 Million | 393.4 Million | 1.6 Million | -910 Thousand | -4.99 Million |
| Other Investing Activities | -4 Million | 295.3 Million | -99 Million | 60.6 Million | 10.62 Million | 13.87 Million |
| Financing Cash Flow | 4.24 Billion | -266.4 Million | 302.6 Million | 2.54 Billion | -1.27 Billion | -447.71 Million |
| Debt repayment | -5.41 Billion | -2.46 Billion | -1.67 Billion | -957.3 Million | -990.5 Million | -818.54 Million |
| Dividends payments | -861.8 Million | -1.07 Billion | -858.6 Million | -750.4 Million | -385.81 Million | -159.04 Million |
| Common Stock Repurchased | - | 2.39 Billion | 1.63 Billion | 883.5 Million | 73.66 Million | 538.25 Million |
| Common Stock Issuance | 25.6 Million | 74.4 Million | 43.1 Million | 73.8 Million | 26.1 Million | 24.31 Million |
| Other Financing Activities | 2.22 Billion | 808.3 Million | 1.16 Billion | 3.29 Billion | -65.78 Million | -32.69 Million |
| Accounts receivables | -851 Million | -2.27 Billion | -515.79 Million | -5.23 Billion | -653.4 Million | -1.49 Billion |
| Accounts payables | 3.34 Billion | -1.68 Billion | -3.01 Billion | 5.59 Billion | 1.12 Billion | 1.86 Billion |
| Inventory | -1.51 Billion | 818.3 Million | -1.74 Billion | -6.6 Billion | -2.23 Billion | -969.03 Million |
| Other working capital | -1.27 Billion | -3.6 Million | 1.85 Billion | 303.3 Million | -234.51 Million | 79.82 Million |
| Cash at beginning of period | 459.5 Million | 753.5 Million | 484.6 Million | 16.9 Million | 29.68 Million | 30.04 Million |
| Cash at end of period | 1.41 Billion | 456.7 Million | 753.5 Million | 484.6 Million | 16.88 Million | 29.68 Million |
| Capital Expenditure | -6.78 Billion | -9.9 Billion | -8.76 Billion | -6.88 Billion | -2.22 Billion | -2.54 Billion |
| Effect of forex changes on cash | 1.7 Million | -8.8 Million | -1.3 Million | 600 Thousand | 860 Thousand | -530 Thousand |
| Net cash flow / Change in cash | 957 Million | -296.8 Million | 268.9 Million | 467.7 Million | -12.8 Million | -360 Thousand |
| Free Cash Flow | -1.81 Billion | 37.4 Million | 342.6 Million | 442.3 Million | 1.25 Billion | 434.01 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 125.1 Million | 756.1 Million | 1.6 Billion | 231.4 Million | 369.5 Million | 248.5 Million |
| Depreciation & Amortization | - | - | 3.84 Billion | 984.1 Million | 933.7 Million | 905.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 109.2 Million | 109.2 Million | - | - | - |
| Change in working capital | - | - | -290.2 Million | - | - | - |
| Other non-cash items | -125.1 Million | -865.3 Million | 6.52 Billion | -231.4 Million | -369.5 Million | -248.5 Million |
| Investing Cash Flow | - | - | -8.28 Billion | - | - | - |
| Investments in PPE | - | - | -6.78 Billion | - | - | - |
| Acquisitions | - | - | -693 Million | - | - | - |
| Investment purchases | - | - | -804.2 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -4 Million | - | - | - |
| Financing Cash Flow | - | - | 4.24 Billion | - | - | - |
| Debt repayment | - | - | -5.41 Billion | - | - | - |
| Dividends payments | - | - | -861.8 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 25.6 Million | - | - | - |
| Other Financing Activities | - | - | 2.22 Billion | - | - | - |
| Accounts receivables | - | - | -851 Million | - | - | - |
| Accounts payables | - | - | 3.34 Billion | - | - | - |
| Inventory | - | - | -1.51 Billion | - | - | - |
| Other working capital | - | - | -1.27 Billion | - | - | - |
| Cash at beginning of period | - | - | 459.5 Million | 671.6 Million | -1.19 Billion | 459.5 Million |
| Cash at end of period | - | - | 1.41 Billion | 2.63 Billion | 671.6 Million | 2.27 Billion |
| Capital Expenditure | - | - | -6.78 Billion | - | - | - |
| Effect of forex changes on cash | - | - | 1.7 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 957 Million | 1.96 Billion | 1.86 Billion | 1.81 Billion |
| Free Cash Flow | - | - | -1.81 Billion | 1.96 Billion | 1.86 Billion | 1.81 Billion |
EVERFIN
SRICHA
BKS
1897
SANGHVIMOV
ALKYLAMINE